PL3498262T3 - Kwas hialuronowy - żel do wstrzykiwania - Google Patents

Kwas hialuronowy - żel do wstrzykiwania

Info

Publication number: PL3498262T3
Authority: PL; Poland
Prior art keywords: hyaluronic acid; injectable gel; acid injectable; gel; hyaluronic
Prior art date: 2007-07-02

Application number

PL19156054T

Other languages

English (en)

Inventor

Samuel Gavard Molliard

Olivier Benoit

Original Assignee

Aptissen Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-07-02

Filing date

2008-07-02

Publication date

2022-02-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39167393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3498262(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-07-02 Application filed by Aptissen Sa filed Critical Aptissen Sa

2022-02-07 Publication of PL3498262T3 publication Critical patent/PL3498262T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Materials Engineering (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Neurosurgery (AREA)
Dispersion Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Physical Education & Sports Medicine (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)

PL19156054T 2007-07-02 2008-07-02 Kwas hialuronowy - żel do wstrzykiwania PL3498262T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
FR0704772A FR2918276B1 (fr)	2007-07-02	2007-07-02	"utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
EP19156054.9A EP3498262B1 (fr)	2007-07-02	2008-07-02	Gel injectable d'acide hyaluronique
PCT/FR2008/000948 WO2009024670A2 (fr)	2007-07-02	2008-07-02	Gel injectable d ' acide hyaluronique pour le traitement des degenerescences articulaires
EP08827889.0A EP2173324B1 (fr)	2007-07-02	2008-07-02	Gel injectable d'acide hyaluronique pour le traitement des degenerescences articulaires

Publications (1)

Publication Number	Publication Date
PL3498262T3 true PL3498262T3 (pl)	2022-02-07

Family

ID=39167393

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL19156054T PL3498262T3 (pl)	2007-07-02	2008-07-02	Kwas hialuronowy - żel do wstrzykiwania
PL08827889T PL2173324T3 (pl)	2007-07-02	2008-07-02	Zastosowanie żelu z polisacharydu(ów) naturalnego(ych) do wytwarzania kompozycji do wstrzykiwania w celu leczenia zwyrodnień stawów

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL08827889T PL2173324T3 (pl)	2007-07-02	2008-07-02	Zastosowanie żelu z polisacharydu(ów) naturalnego(ych) do wytwarzania kompozycji do wstrzykiwania w celu leczenia zwyrodnień stawów

Country Status (14)

Country	Link
US (1)	US9138405B2 (pl)
EP (2)	EP3498262B1 (pl)
JP (1)	JP5517133B2 (pl)
KR (1)	KR20100028582A (pl)
CN (2)	CN104825482A (pl)
BR (1)	BRPI0813011B8 (pl)
CA (1)	CA2691600C (pl)
ES (2)	ES2898939T3 (pl)
FR (1)	FR2918276B1 (pl)
HU (1)	HUE056793T2 (pl)
PL (2)	PL3498262T3 (pl)
PT (2)	PT2173324T (pl)
TR (1)	TR201909779T4 (pl)
WO (1)	WO2009024670A2 (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2945949B1 (fr) *	2009-05-26	2011-05-13	Anteis Sa	Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme.
US8273725B2 (en)	2009-09-10	2012-09-25	Genzyme Corporation	Stable hyaluronan/steroid formulation
FR2954165B1 (fr)	2009-12-18	2012-01-13	Jean-Noel Thorel	Compositions injectables a usage intra-articulaire associant un agent de viscosupplementation et un milieu de croissance des fibroblastes
JP5457238B2 (ja) *	2010-03-17	2014-04-02	電気化学工業株式会社	ヒアルロン酸及び／又はその塩の含有液の加熱滅菌方法
IT1402382B1 (it)	2010-09-09	2013-09-04	Ibsa Inst Biochimique Sa	Complessi cooperativi ibridi di acido ialuronico
US8455436B2 (en)	2010-12-28	2013-06-04	Depuy Mitek, Llc	Compositions and methods for treating joints
US8398611B2 (en)	2010-12-28	2013-03-19	Depuy Mitek, Inc.	Compositions and methods for treating joints
US8524662B2 (en)	2010-12-28	2013-09-03	Depuy Mitek, Llc	Compositions and methods for treating joints
WO2012143876A1 (en) *	2011-04-19	2012-10-26	Anteis S.A.	A sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
US8623839B2 (en) *	2011-06-30	2014-01-07	Depuy Mitek, Llc	Compositions and methods for stabilized polysaccharide formulations
GB201118586D0 (en) *	2011-10-27	2011-12-07	Turzi Antoine	New A-PRP medical device, manufacturing machine and process
WO2013076162A1 (en) *	2011-11-21	2013-05-30	Université Libre de Bruxelles	Formulations useful in the treatment of osteoarticular diseases
WO2013076160A1 (en) *	2011-11-21	2013-05-30	Université Libre de Bruxelles	Sustained release formulations useful in the treatment of diseases
FR2991876B1 (fr)	2012-06-13	2014-11-21	Vivacy Lab	Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2994846B1 (fr)	2012-08-29	2014-12-26	Vivacy Lab	Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
RU2015133465A (ru) *	2013-01-11	2017-02-16	Карбилан Терапьютикс, Инк.	Стабилизированные композиции, содержащие гиалуроновую кислоту
PT3019177T (pt)	2013-07-10	2020-12-30	Matrix Biology Inst	Composições de hialuronano de elevada elasticidade e suas utilizações
KR101582380B1 (ko) *	2013-09-11	2016-01-05	주식회사 제네웰	손상 조직에 대한 세포 전달 및 조직 재생용 생체재료와 제조방법
AU2014352672B2 (en)	2013-11-25	2018-11-29	Deuteria Biomaterials, Llc	Deuterium-enriched hyaluronan
US9682099B2 (en)	2015-01-20	2017-06-20	DePuy Synthes Products, Inc.	Compositions and methods for treating joints
FR3032617B1 (fr) *	2015-02-16	2018-03-16	Kylane Laboratoires Sa	Procede de preparation d un hydrogel injectable; hydrogel obtenu; utilisation de l hydrogel obtenu
HUE054874T2 (hu)	2015-09-24	2021-10-28	Matrix Biology Inst	Magas elaszticitású hialuronán készítmények és alkalmazási eljárások
CN105879124B (zh) *	2016-04-26	2019-03-19	华熙福瑞达生物医药有限公司	一种注射用左旋聚乳酸填充剂及其制备方法
KR101916193B1 (ko)	2016-08-25	2018-11-07	주식회사 파마리서치프로덕트	핵산 및 키토산을 포함하는 관절강 주사용 조성물
US10576099B2 (en)	2016-10-21	2020-03-03	Covidien Lp	Injectable scaffold for treatment of intracranial aneurysms and related technology
FR3063649B1 (fr) *	2017-03-07	2021-05-21	Laboratoire De Rhumatologie Appliquee	Nouvelle solution visco-elastique et son utilisation en rhumatologie
IL272630B2 (en)	2017-08-22	2023-09-01	Moebius Medical Ltd	Liposomal formulations for joint lubrication
IT201800007683A1 (it)	2018-07-31	2020-01-31	Altergon Sa	Composizioni cooperative sinergiche utili per aumento del tessuto molle, rilascio di farmaco e campi correlati
KR102566287B1 (ko) *	2018-11-30	2023-08-11	주식회사 엘지화학	히알루론산을 포함하는 활액보충재용 조성물
WO2020154305A1 (en)	2019-01-21	2020-07-30	Eclipse Medcorp, Llc	Methods, systems and apparatus for separating components of a biological sample
US12007382B2 (en)	2019-10-31	2024-06-11	Crown Laboratories, Inc.	Systems, methods and apparatus for separating components of a sample
WO2021092618A1 (en)	2019-11-04	2021-05-14	Covidien Lp	Devices, systems, and methods for treatment of intracranial aneurysms
EP3854377A1 (fr) *	2020-01-22	2021-07-28	Laboratoires Genevrier Sas	Composition comprenant de l'acide hyaluronique et un polyol ou de carboxyméthylcellulose
WO2022198208A1 (en)	2021-03-16	2022-09-22	Covidien Lp	Injectable biopolymer compositions and associated systems and methods
WO2025133721A1 (en) *	2023-12-19	2025-06-26	Universidade Nova De Lisboa	Injectable composition of nonsteroidal anti-inflammatory drugs, methods and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL80298A (en) *	1986-10-14	1993-01-31	Res & Dev Co Ltd	Eye drops
US5079236A (en)	1987-05-27	1992-01-07	Hyal Pharmaceutical Corporation	Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
EP0297860B1 (en) *	1987-07-01	1993-09-01	Genentech, Inc.	Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
JP2788340B2 (ja) *	1989-12-21	1998-08-20	株式会社ニッショー	炎症治療剤
US5095037B1 (en) *	1989-12-21	1995-12-19	Nissho Kk	Combined anti-inflammatory agent
CA2060223C (en) *	1991-02-12	1999-07-20	Clarence C. Lee	Injectable medical lubricating fluid composition and method of use
US7968110B2 (en) *	1992-02-11	2011-06-28	Merz Aesthetics, Inc.	Tissue augmentation material and method
IT1291291B1 (it) *	1997-04-30	1999-01-07	Chemedica Sa	Uso di acido ialuronico e relativi sali per la preparazione di una soluzione acquosa utile come liquido di lavaggio intra-articolare
JP5105697B2 (ja) *	2002-01-18	2012-12-26	シヴィダ・インコーポレイテッド	コドラッグのコントロールデリバリ用ポリマー性ゲルシステム
WO2004073759A1 (en)	2003-02-19	2004-09-02	Aventis Pharmaceuticals Holdings Inc.	Composition and method for intradermal soft tissue augmentation
US20050208095A1 (en) *	2003-11-20	2005-09-22	Angiotech International Ag	Polymer compositions and methods for their use
FR2865737B1 (fr)	2004-02-03	2006-03-31	Anteis Sa	Gel reticule biocompatible
US20050215516A1 (en)	2004-03-29	2005-09-29	Claudio Bucolo	New free-radical scavenger containing viscoelastic composition, methods of use and package
US20060040894A1 (en) *	2004-08-13	2006-02-23	Angiotech International Ag	Compositions and methods using hyaluronic acid
WO2006067608A1 (en) *	2004-12-22	2006-06-29	Laboratoire Medidom S.A.	Aqueous formulations based on sodium hyaluronate for parenteral use
FR2895907B1 (fr)	2006-01-06	2012-06-01	Anteis Sa	Gel viscoelastique a usage dermatologique
FR2909560B1 (fr)	2006-12-06	2012-12-28	Fabre Pierre Dermo Cosmetique	Gel d'acide hyaluronique pour injection intradermique

2007
- 2007-07-02 FR FR0704772A patent/FR2918276B1/fr active Active
2008
- 2008-07-02 BR BRPI0813011A patent/BRPI0813011B8/pt active IP Right Grant
- 2008-07-02 KR KR20097027301A patent/KR20100028582A/ko not_active Ceased
- 2008-07-02 WO PCT/FR2008/000948 patent/WO2009024670A2/fr not_active Ceased
- 2008-07-02 ES ES19156054T patent/ES2898939T3/es active Active
- 2008-07-02 EP EP19156054.9A patent/EP3498262B1/fr active Active
- 2008-07-02 PL PL19156054T patent/PL3498262T3/pl unknown
- 2008-07-02 ES ES08827889T patent/ES2735376T3/es active Active
- 2008-07-02 CN CN201510090635.XA patent/CN104825482A/zh active Pending
- 2008-07-02 JP JP2010514043A patent/JP5517133B2/ja active Active
- 2008-07-02 US US12/667,627 patent/US9138405B2/en active Active
- 2008-07-02 CA CA2691600A patent/CA2691600C/fr active Active
- 2008-07-02 CN CN200880023126A patent/CN101686936A/zh active Pending
- 2008-07-02 TR TR2019/09779T patent/TR201909779T4/tr unknown
- 2008-07-02 HU HUE19156054A patent/HUE056793T2/hu unknown
- 2008-07-02 PL PL08827889T patent/PL2173324T3/pl unknown
- 2008-07-02 PT PT08827889T patent/PT2173324T/pt unknown
- 2008-07-02 EP EP08827889.0A patent/EP2173324B1/fr active Active
- 2008-07-02 PT PT191560549T patent/PT3498262T/pt unknown

Also Published As

Publication number	Publication date
ES2898939T3 (es)	2022-03-09
EP3498262B1 (fr)	2021-09-01
US9138405B2 (en)	2015-09-22
JP5517133B2 (ja)	2014-06-11
BRPI0813011B1 (pt)	2019-10-08
EP2173324A2 (fr)	2010-04-14
CN104825482A (zh)	2015-08-12
JP2010531863A (ja)	2010-09-30
CA2691600A1 (fr)	2009-02-26
PT2173324T (pt)	2019-07-09
BRPI0813011A2 (pt)	2014-12-23
CA2691600C (fr)	2017-01-10
FR2918276A1 (fr)	2009-01-09
ES2735376T3 (es)	2019-12-18
BRPI0813011B8 (pt)	2021-05-25
PL2173324T3 (pl)	2019-09-30
EP2173324B1 (fr)	2019-04-10
HUE056793T2 (hu)	2022-03-28
TR201909779T4 (tr)	2019-07-22
CN101686936A (zh)	2010-03-31
EP3498262A1 (fr)	2019-06-19
WO2009024670A3 (fr)	2009-04-23
FR2918276B1 (fr)	2010-01-22
KR20100028582A (ko)	2010-03-12
US20100184720A1 (en)	2010-07-22
WO2009024670A2 (fr)	2009-02-26
PT3498262T (pt)	2021-11-11

Publication	Publication Date	Title
PL3498262T3 (pl)	2022-02-07	Kwas hialuronowy - żel do wstrzykiwania
ZA200903919B (en)	2010-06-30	Hyaluronic acid gel for intradermal injection
GB0816496D0 (en)	2008-10-15	Hyaluronic acid cryogel
SG10202104803SA (en)	2021-06-29	Hyaluronic Acid-Based Gels Including Anesthetic Agents
ZA201007022B (en)	2012-03-28	Carbohydrate gel
IL237391A0 (en)	2015-04-30	Pharmaceutical combination
PL2918172T3 (pl)	2019-06-28	Połączenia środków kontroli biologicznej i fungicydów
IL207798A0 (en)	2010-12-30	Furlable shape-memory relector
PL2011816T3 (pl)	2017-07-31	Ko-sieciowany żel polisacharydowy
PL3566713T3 (pl)	2021-12-06	Wstrzykiwalne biomateriały
GB0810615D0 (en)	2008-07-16	Novel pharmaceutical
IL208953A0 (en)	2011-01-31	Pharmaceutical combination
GB0917736D0 (en)	2009-11-25	Gel composition
GB0810617D0 (en)	2008-07-16	Novel pharmaceutical
GB0818926D0 (en)	2008-11-19	Sealant
GB0801321D0 (en)	2008-03-05	Gel composition
HU0800414D0 (en)	2008-08-28	Pharmaceutical combination
GB0811637D0 (en)	2008-07-30	Hyaluronic acid crtogel
GB0813299D0 (en)	2008-08-27	Injectable medications
AU2009901028A0 (en)	2009-04-02	Injectable biomaterials
GB0820320D0 (en)	2008-12-17	Biomaterials
GB0807271D0 (en)	2008-05-28	Syringes
GB0804486D0 (en)	2008-04-16	Novel pharmaceutical composituons
GB0719869D0 (en)	2007-11-21	Biomaterials
GB0712320D0 (en)	2007-08-01	Gel capacitor